Showing results (271-280 of 326) with videos related to
Sort By:
Pageof 33
Journal of Cardiology Cases|December 12, 2018
A case of human immunodeficiency virus-related heart failure resembling dilated cardiomyopathy but accompanied by high cardiac outputNoriaki Tabata, Megumi Yamamuro, Seigo Sugiyama, et al.European Journal of Medicinal Chemistry|February 9, 2024
Exploration of P1 and P4 modifications of nirmatrelvir: Design, synthesis, biological evaluation, and X-ray structural studies of SARS-CoV-2 Mpro inhibitorsArun K Ghosh, Monika Yadav, Satyanarayana Iddum, et al.CEN Case Reports|March 10, 2022
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infectionHiroko Beppu, Toshie Ogawa, Masahiro Ishikane, et al.RSC Medicinal Chemistry|October 7, 2024
Discovery of a nasal spray steroid, tixocortol, as an inhibitor of SARS-CoV-2 main protease and viral replicationDavid A Davis, Ashwin Nair, Yana Astter, et al.The Journal of Biological Chemistry|October 20, 2009
Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitorEleftherios Michailidis, Bruno Marchand, Eiichi N Kodama, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 24, 2023
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant waveShohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.Molecules (Basel, Switzerland)|October 13, 2021
Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease InhibitorsArun K Ghosh, Dana Shahabi, Monika Yadav, et al.Scientific Reports|March 5, 2021
A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodiesKenta Noda, Kouki Matsuda, Shigehiro Yagishita, et al.Journal of Medicinal Chemistry|April 19, 2017
Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV VariantsArun K Ghosh, Kalapala Venkateswara Rao, Prasanth R Nyalapatla, et al.Journal of Medicinal Chemistry|September 15, 2009
Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistanceArun K Ghosh, Sarang Kulkarni, David D Anderson, et al.Pageof 33